Advertisement
U.S. markets closed
Advertisement

International Stem Cell Corporation (ISCO)

Other OTC - Other OTC Delayed Price. Currency in USD
0.12100.0000 (0.00%)
At close: 10:11AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1210
Open0.1210
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1210 - 0.1210
52 Week Range0.0600 - 0.4000
Volume3
Avg. Volume1,895
Market Cap968,531
Beta (5Y Monthly)0.58
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ISCO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • INTERNATIONAL STEM CELL CORPORA
    Analyst Report: Thermo Fisher Scientific Inc.Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).
    Rating
    Fair Value
    Economic Moat
    26 days agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.